BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 21710489)

  • 1. Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor.
    Duffy MM; Pindjakova J; Hanley SA; McCarthy C; Weidhofer GA; Sweeney EM; English K; Shaw G; Murphy JM; Barry FP; Mahon BP; Belton O; Ceredig R; Griffin MD
    Eur J Immunol; 2011 Oct; 41(10):2840-51. PubMed ID: 21710489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
    Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
    Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated T-cells and pro-inflammatory cytokines differentially regulate prostaglandin E2 secretion by mesenchymal stem cells.
    Hegyi B; Kudlik G; Monostori E; Uher F
    Biochem Biophys Res Commun; 2012 Mar; 419(2):215-20. PubMed ID: 22333568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1α,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells.
    Ikeda U; Wakita D; Ohkuri T; Chamoto K; Kitamura H; Iwakura Y; Nishimura T
    Immunol Lett; 2010 Nov; 134(1):7-16. PubMed ID: 20655952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation.
    Carrión F; Nova E; Luz P; Apablaza F; Figueroa F
    Immunol Lett; 2011 Mar; 135(1-2):10-6. PubMed ID: 20888363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
    Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
    Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E₂ down-regulates the expression of CD25 on bovine T cells, and this effect is mediated through the EP4 receptor.
    Maślanka T; Spodniewska A; Barski D; Jasiecka A; Zuśka-Prot M; Ziółkowski H; Markiewicz W; Jaroszewski JJ
    Vet Immunol Immunopathol; 2014 Aug; 160(3-4):192-200. PubMed ID: 25001909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFN-gamma production by memory CD4+ T cells.
    Napolitani G; Acosta-Rodriguez EV; Lanzavecchia A; Sallusto F
    Eur J Immunol; 2009 May; 39(5):1301-12. PubMed ID: 19384872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis.
    Zhang X; Tao Y; Troiani L; Markovic-Plese S
    J Immunol; 2011 Sep; 187(6):3431-7. PubMed ID: 21856936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.
    Ghannam S; Pène J; Moquet-Torcy G; Jorgensen C; Yssel H
    J Immunol; 2010 Jul; 185(1):302-12. PubMed ID: 20511548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells.
    Yañez R; Oviedo A; Aldea M; Bueren JA; Lamana ML
    Exp Cell Res; 2010 Nov; 316(19):3109-23. PubMed ID: 20804749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.
    Sharma S; Yang SC; Zhu L; Reckamp K; Gardner B; Baratelli F; Huang M; Batra RK; Dubinett SM
    Cancer Res; 2005 Jun; 65(12):5211-20. PubMed ID: 15958566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism.
    Djouad F; Charbonnier LM; Bouffi C; Louis-Plence P; Bony C; Apparailly F; Cantos C; Jorgensen C; Noël D
    Stem Cells; 2007 Aug; 25(8):2025-32. PubMed ID: 17510220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synovial fibroblasts directly induce Th17 pathogenicity via the cyclooxygenase/prostaglandin E2 pathway, independent of IL-23.
    Paulissen SM; van Hamburg JP; Davelaar N; Asmawidjaja PS; Hazes JM; Lubberts E
    J Immunol; 2013 Aug; 191(3):1364-72. PubMed ID: 23817417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis.
    Ohshima M; Yamahara K; Ishikane S; Harada K; Tsuda H; Otani K; Taguchi A; Miyazato M; Katsuragi S; Yoshimatsu J; Kodama M; Kangawa K; Ikeda T
    J Mol Cell Cardiol; 2012 Sep; 53(3):420-8. PubMed ID: 22796574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phagocytosis of apoptotic cells modulates mesenchymal stem cells osteogenic differentiation to enhance IL-17 and RANKL expression on CD4+ T cells.
    Tso GH; Law HK; Tu W; Chan GC; Lau YL
    Stem Cells; 2010 May; 28(5):939-54. PubMed ID: 20222014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.
    Mus AM; Cornelissen F; Asmawidjaja PS; van Hamburg JP; Boon L; Hendriks RW; Lubberts E
    Arthritis Rheum; 2010 Apr; 62(4):1043-50. PubMed ID: 20131264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell-intrinsic prostaglandin E
    Lee J; Aoki T; Thumkeo D; Siriwach R; Yao C; Narumiya S
    J Allergy Clin Immunol; 2019 Feb; 143(2):631-643. PubMed ID: 29935220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-23-dependent and -independent enhancement pathways of IL-17A production by lactic acid.
    Yabu M; Shime H; Hara H; Saito T; Matsumoto M; Seya T; Akazawa T; Inoue N
    Int Immunol; 2011 Jan; 23(1):29-41. PubMed ID: 21131367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.